Fresenius Medical Care AG (STU:FMEA) 1-Year Sharpe Ratio: N/A (As of Sep. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:FMEA Fresenius Medical Care AG STU:FMEA
76 GF Score
Price €19.40
GF Value €21.13
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG 1-Year Sharpe Ratio?

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-09-04), Fresenius Medical Care AG's 1-Year Sharpe Ratio is Not available.

Fresenius Medical Care AG  (STU:FMEA) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Fresenius Medical Care AG 1-Year Sharpe Ratio Related Terms

STU:FMEA vs HCA, THC, EHC: 1-Year Sharpe Ratio Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresenius Medical Care AG 1-Year Sharpe Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's 1-Year Sharpe Ratio falls into.


STU:FMEA
76GF Score
Fresenius Medical Care AG STU:FMEA
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Is Fresenius Medical Care AG (STU:FMEA) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of €19.40 is trading 8.2% below its estimated GF Value™ of €21.13. GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.

Key valuation signals for STU:FMEA:

  • 1-Year Sharpe Ratio: N/A
  • GF Value™: €21.13 vs. price of €19.40 (8.2% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the STU:FMEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
76GF Score

Get the complete analysis for STU:FMEA

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€19.40
Price
€21.13
GF Value